Gatifloxacin | CAS 112811-59-3

Gatifloxacin | CAS 112811-59-3

Gatifloxacin | CAS 112811-59-3 is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.
Send Inquiry
Description
What is Gatifloxacin | CAS 112811-59-3

 

Gatifloxacin | CAS 112811-59-3 is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

 

Benefits of Gatifloxacin | CAS 112811-59-3

Gatifloxacin | CAS 112811-59-3 is a synthetic broad-spectrum 8-methoxyfluoroquinolone antibacterial agent for oral or intravenous administration. is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian.

 

Gatifloxacin | CAS 112811-59-3 is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

 

Related Products
 
奥拉帕尼 CAS #763113-22-0

Olaparib CAS #763113-22-0

Olaparib is a kind of novel poly ADP-ribose polymerase (PARP) inhibitors, including PARP1, PARP2, and PARP3.

巴洛沙韦 CAS #1985605-59-1

Baloxavir CAS #1985605-59-1

Baloxavir is a drug employed in the treatment of influenza virus infection. Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease.

Finerenone CAS #1050477-31-0

Finerenone CAS #1050477-31-0

Finerenone is a novel mineralocorticoid receptor antagonist that has the effect of delaying the progression of chronic kidney disease.

奥希替尼 CAS #1421373-65-0

Osimertinib CAS #1421373-65-0

Osimertinib is a member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group.

米罗巴林苯磺酸盐 CAS #1138245-21-2

Mirogabalin Besylate CAS #1138245-21-2

Mirogabalin besylate (mirogabalin, Tarlige) is a gabapentinoid therapy developed by Daiichi Sankyo

莫西沙星 CAS #151096-09-2

Moxifloxacin CAS #151096-09-2

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039)

伊马替尼 CAS #152459-95-5

Imatinib CAS #152459-95-5

Imatinib is a kind of oral drugs used for the treatment of the chronic myelogenous leukemia (abbreviated CML) of positive symptoms of Philadelphia chromosome (Ber-Abl).

product-730-730

Azithromycin CAS# 83905-01-5

Product description:Azithromycin was the first of the azalides and was designed to improve the stability and biological half-life of erythromycin A, as well as improve activity against Gram negative bacteria.

product-730-730

Vinpocetine CAS# 42971-09-5

Vinpocetine is a cerebrovascular expansion drug and has a relatively stronger function than Vincamine.

 

Why Choose us

 

Excellent Team
The company has hired senior experts and PhDs in the field of biochemical synthesis in China to lead the guidance, and has a leading core team consisting of senior engineer Zeng Fanrong with a master's degree and multiple undergraduate research and development personnel.

 

Quality Services
Team members possess multilingual skills and are able to adapt to the diverse needs of the international market, establishing stable cooperative relationships with global clients.

 

Quality Assurance
We produce merchandise of the highest possible standard. Possessing the technology and skills to reach the requirements of our clients, we ensure that the merchandise produced reflects our commitment to providing our clients with a fast, reliable and cost-effective service without compromising on quality.

 

The Following Factors Should Be Considered When Using Gatifloxacin | CAS 112811-59-3

Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

 

Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of gatifloxacin eye drops in the elderly.

 

Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

 

Drug Interactions
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription medicine.

 

Other Interactions
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

 

Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Corneal problems-Use with caution. May make these conditions worse.

 

Dosing
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

 

Gatifloxacin | CAS 112811-59-3
How to Use Gatifloxacin | CAS 112811-59-3

Use this medication in the affected eye(s) as directed by your doctor, usually 3 times a day for the first 2 days and then 2 times a day for the next 5 days.

For best results, use exactly as directed for the full time prescribed. Stopping this medication too soon may result in a return of the infection.

To apply eye drops, wash hands first. To avoid contamination, do not touch the dropper tip or let it touch your eye or any other surface.

Tilt your head back, gaze upward and pull down the lower eyelid to make a pouch. Place the dropper directly over eye and instill the prescribed number of drops. Look downward and gently close your eye for 1 to 2 minutes. Place one finger at the corner of the eye near the nose and apply gentle pressure. This will prevent the medication from draining away from the eye. Try not to blink and do not rub the eye. Do not rinse the dropper.

If you are using other kinds of eye drops, wait at least five minutes before applying the other medications.

Wait several minutes for your vision to clear before driving or operating machinery.

Do not wear contact lenses while you are using this medicine. Sterilize contact lenses according to manufacturer's directions and check with your doctor before using them.

 

Gatifloxacin | CAS 112811-59-3 Drug Interaction Checklist
 

Safety Advice
Safety warning
Alcohol
The interaction of alcohol with gatifloxacin | CAS 112811-59-3 is not known. Consult your doctor before consuming alcohol while on treatment with gatifloxacin | CAS 112811-59-3.

 

Safety Warning
Pregnancy
It is not known whether gatifloxacin | CAS 112811-59-3 will affect pregnant women. Therefore, consult a doctor before using gatifloxacin | CAS 112811-59-3 if you are pregnant.

 

Safety Warning
Breast feeding
It is unknown if gatifloxacin | CAS 112811-59-3 passes into breastmilk. Consult your doctor before taking gatifloxacin | CAS 112811-59-3 if you are breastfeeding.

 

Safety Warning
Driving
Gatifloxacin | CAS 112811-59-3 usually causes temporarily blurred vision. Therefore, avoid driving or operating machinery until your vision is clear.

 

Safety Warning
Liver
Caution
Please consult your doctor if you have any liver problems.

 

Safety Warning
Kidney
Please consult your doctor if you have any kidney problems.

 

Safety Warning
Children
Gatifloxacin | CAS 112811-59-3 is not recommended for children below 1 year of age. However, please consult a doctor before giving gatifloxacin | CAS 112811-59-3 to children.

 

 
Company Introduction

 

Huarong (Guangdong) Pharmaceutical Co., Ltd. is a pharmaceutical intermediate manufacturing and production company, based on the synthesis of DPP-4 inhibitor intermediates. It comprehensively constructs a production line for active ingredients of bisamide insecticides, as well as a multifunctional production line for chiral synthesis and enzymatic synthesis of compound intermediates. Build an advanced and green comprehensive production base for pharmaceutical and pesticide intermediates.

The company was established on November 8, 2023, with a type of other limited liability company and registered in Nanxiong City, Shaoguan City. The company's project plan covers an area of 53406.97 square meters. The main building includes 5 Class A multifunctional workshops, 1 Class C workshop, 1 comprehensive building, 1 quality inspection and research and development building, as well as supporting power and environmental protection facilities. The construction of the project covers an area of 19042 square meters, with a building area of 50137 square meters and a plot ratio of 0.94.

product-1-1

 

 
Asked Questions
 

Q: What are the precautions for bilirubin CAS 635-65-4?

A: Call your doctor right away if you or your child have a rash, itching, red or swollen skin around the eye or eyelid, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth while you are using this medicine. Serious skin reactions can occur with this medicine.

Q: What is the half life of bilirubin CAS 635-65-4?

A: The mean elimination half-life of bilirubin CAS 635-65-4 ranges from 7 to 14 hours and is independent of dose and route of administration. Renal clearance is independent of dose with mean value ranging from 124 to 161 ml/min.

Q: What does bilirubin CAS 635-65-4 do for the eye?

A: Bilirubin CAS 635-65-4 eye drops are used to treat infections of the eye, such as bacterial conjunctivitis. Bilirubin CAS 635-65-4 belongs to a group of medicines called fluoroquinolone antibiotics. It works by killing bacteria that cause conjunctivitis. This medicine is available only with your doctor's prescription.

Q: Does bilirubin CAS 635-65-4 have any drug interactions?

A: The risk or severity of qtc prolongation can be increased when bilirubin CAS 635-65-4 is combined with cinoxacin. The risk or severity of qtc prolongation can be increased when bilirubin CAS 635-65-4 is combined with ciprofloxacin. The risk or severity of qtc prolongation can be increased when bilirubin CAS 635-65-4 is combined with cisapride.

Q: What class of antibiotic is bilirubin CAS 635-65-4?

A: Bilirubin CAS 635-65-4 is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infection.

Q: Is bilirubin CAS 635-65-4 a steroid?

A: No. Bilirubin CAS 635-65-4 (zymaxid) isn't a steroid or corticosteroid. It's an antibiotic eye drop that kills bacteria causing pink eye. If you have a severe eye infection, your provider might prescribe a steroid medication along with bilirubin CAS 635-65-4 (zymaxid) to help with the swelling.

Q: Does bilirubin CAS 635-65-4 cause qt prolongation?

A: This points to the fact that in normal population 8-10% of patients may get qtc interval prolongation with administration of usual therapeutic dose of bilirubin CAS 635-65-4 i.E.400 mg per day (if our sample represents the general population).

Q: Can bilirubin CAS 635-65-4 treat eye infection?

A: Bilirubin CAS 635-65-4 is a quinolone antibiotic used to treat bacterial eye infections (such as conjunctivitis). What does bilirubin CAS 635-65-4 do? In fact, the drug bilirubin CAS 635-65-4 only works when the eye is attacked by bacteria and will not be effective against eye infections caused by other agents such as viruses or fungi.

Q: Is bilirubin CAS 635-65-4 in urine?

A: Bilirubin CAS 635-65-4 has a large volume of distribution, low protein binding, and broad tissue distribution. The majority of an administered dose is excreted unchanged in urine. It can be given without dose modification in patients with hepatic impairment, in women, and in the elderly.

Q: Can bilirubin CAS 635-65-4 cause diarrhea?

A: Gastrointestinal side effects have included nausea (8%) and diarrhea (4%). Other gastrointestinal effects reported in 0.1% to 3% of patients include abdominal pain, anorexia, constipation, dyspepsia, flatulence, gastritis, glossitis, mouth ulcer, oral moniliasis, stomatitis, and vomiting.

Q: Can bilirubin CAS 635-65-4 cause hypoglycemia?

A: Bilirubin CAS 635-65-4 can cause both hypoglycemia and hyperglycemia in both diabetic and non-diabetic patients. Bilirubin CAS 635-65-4 recently has been reported to stimulate insulin secretion by inhibition of atp-sensitive k(+) (k(atp)) channels in pancreatic beta-cells.

Q: What is the use of bilirubin CAS 635-65-4 in ophthalmology?

A: What is bilirubin CAS 635-65-4 ophthalmic? Bilirubin CAS 635-65-4 is a fluoroquinolone antibiotic that fights bacteria. Bilirubin CAS 635-65-4 ophthalmic (for the eyes) is used to treat eye infections caused by bacteria. Bilirubin CAS 635-65-4 ophthalmic may also be used for purposes not listed in this medication guide.

Hot Tags: gatifloxacin | cas 112811-59-3, China gatifloxacin | cas 112811-59-3 manufacturers, suppliers, 4 bromopyridine hydrochloride, , , Veterinary raw materials